Cargando…
Identification of Circulating Serum miRNAs as Novel Biomarkers in Pancreatic Cancer Using a Penalized Algorithm
Pancreatic cancer (PC) is difficult to detect in the early stages; thus, identifying specific and sensitive biomarkers for PC diagnosis is crucial, especially in the case of early-stage tumors. Circulating microRNAs are promising non-invasive biomarkers. Therefore, we aimed to identify non-invasive...
Autores principales: | Lee, Jaehoon, Lee, Hee Seung, Park, Soo Been, Kim, Chanyang, Kim, Kahee, Jung, Dawoon E., Song, Si Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863930/ https://www.ncbi.nlm.nih.gov/pubmed/33498271 http://dx.doi.org/10.3390/ijms22031007 |
Ejemplares similares
-
CG200745, an HDAC inhibitor, induces anti-tumour effects in cholangiocarcinoma cell lines via miRNAs targeting the Hippo pathway
por: Jung, Dawoon E., et al.
Publicado: (2017) -
Identification of potential biomarkers for diagnosis of pancreatic and biliary tract cancers by sequencing of serum microRNAs
por: Kim, Kwondo, et al.
Publicado: (2019) -
GLRX3, a novel cancer stem cell-related secretory biomarker of pancreatic ductal adenocarcinoma
por: Jo, Jung Hyun, et al.
Publicado: (2021) -
Novel Gastric Cancer Stem Cell-Related Marker LINGO2 Is Associated with Cancer Cell Phenotype and Patient Outcome
por: Jo, Jung Hyun, et al.
Publicado: (2019) -
Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer
por: Zekri, Abdel-Rahman N., et al.
Publicado: (2016)